Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$145.83
▼ $1.17 (-0.8%)
Market data updated: 09/16 11:35 PM
Fundamentals updated: 09/16/2026
News analyzed: 09/16/2026
Market Cap
$81.34B
Day Range
$144.40 - $148.94
52-Week Range
$122.64 - $166.35
Beta
—
Next Earnings
03.11.2026
EMR is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
+13.0% (1Y)
Strengths: 7/29 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Leverage risk
Debt/equity: 0.44
Risk
Biggest negative driver
DCF Fair Value
Estimated fair value: $73.63 vs. price $145.83 (-49.5%)
Fair Value
What to watch next
When today echoes the past.
83/100
Similarity
15
Historical Matches
91/100
Analog Quality
+3.0%
Median 40D Outcome
50/100
Pattern Consistency
🟢 Bullish
60%
+3.2% … +4.9%
🟡 Base
7%
-0.6% … -0.6%
🔴 Bearish
33%
-7.6% … -5.7%
Typical timeframe (based on real historical rates clearing a 60% bar): 20 trading days.
📌 Bottom line: Out of 15 similar historical cases for this stock, 60% (95% CI 36%–80%) saw the stock rise within 20 trading days, with a median gain of +2.2%.
Echo #1 — Oversold Reversal
2 occurrence(s) · 50% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 47% (25%–70%) | +0.6% | -3.0% … +3.5% | +0.4% |
| 10D | 47% (25%–70%) | -0.2% | -2.2% … +3.5% | +0.6% |
| 20D | 60% (36%–80%) | +2.2% | -5.6% … +4.6% | +1.6% |
| 40D | 60% (36%–80%) | +3.0% | -2.5% … +10.1% | +2.5% |
| 60D | 67% (42%–85%) | +5.0% | -0.8% … +13.0% | +3.1% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2025-03-03 | 83/100 | ✓ Consolidation | -6.4% | +2.2% |
| 2018-04-09 | 82/100 | ✓ Consolidation | +4.7% | +3.9% |
| 2020-02-18 | 81/100 | Consolidation | -33.6% | -27.4% |
| 2020-09-22 | 81/100 | ✓ Consolidation | +7.3% | +24.6% |
| 2025-09-26 | 80/100 | Consolidation | +3.2% | +5.0% |
| 2026-05-04 | 80/100 | Consolidation | +4.9% | +9.7% |
| 2021-10-04 | 80/100 | ✓ Consolidation | +4.5% | -0.7% |
| 2025-01-06 | 79/100 | ✓ Consolidation | +2.2% | -16.5% |
| 2025-11-18 | 79/100 | ✓ Consolidation | +3.9% | +17.4% |
| 2021-11-29 | 79/100 | Downtrend | +2.2% | -0.9% |
| 2023-05-02 | 78/100 | Downtrend | -5.5% | +10.6% |
| 2023-10-30 | 77/100 | Consolidation | -0.6% | +7.5% |
| 2023-02-16 | 77/100 | Consolidation | -5.7% | -3.0% |
| 2022-09-02 | 77/100 | Downtrend | -7.6% | +15.4% |
| 2023-05-23 | 77/100 | Downtrend | +7.8% | +18.1% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLI (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
49
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
56
Quality
55
Value
33
Momentum
23
Risk
40
Sentiment
98
Fundamental
61
Institutional
0
Stocks with a similar DNA right now
SCANNING EMR...
Recent media coverage of Emerson Electric has been limited and indirect, with no direct headlines or summaries specifically about the company. The provided sources focus on unrelated topics, including other firms like MMM, Eaton, Vertiv, and A.O. Smith, as well as general dividend discussions and market analyses. No explicit details about Emerson Electric’s performance, strategy, or recent developments are available in the given sources.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Emerson Electric. News trend score: 98. Reason: 11 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
31
🎯 Conviction (vs. Emotion)
40
Psychology
52
Fundamentals
61
Technical
23
Valuation
33
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
The price rise has far outpaced the actual improvement in fundamental data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-3%
Market Narrative
69
Fundamental Reality
40
Narrative Gap
+29
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests a disconnect between fundamentals and valuation, with overconfidence dominating (score 45) as price far exceeds DCF estimates despite weak momentum. Herding (39) and euphoria (36) reinforce this, as peers underperform but sentiment remains positive. The key open question is whether the narrative gap (34 points) reflects overoptimism or a delayed reaction to improving fundamentals. The absence of panic or loss aversion signals complacency despite valuation extremes.
Updated: 09/08/2026, 09:40 PM
What could change this?
👥 What the crowd believes
"Strength in Transportation & Electronics Unit Drives 3M: A Sign of More Upside? — MMM's Transportation & Electronics strength, led by semiconductor, data center and aerospace growth"
"analysts are moderately bullish about EMR stock"
"Emerson Electric has outperformed the Nasdaq Composite over the past three months"
📈 7D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 93/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 2/100
🗣️ Why do they disagree?
The methodologies here split sharply between bullish and cautious views on EMR, reflecting starkly different priorities. Samuel Armstrong Nelson and Edgar Lawrence Smith both see strong potential—Nelson highlights a favorable cycle position near oversold levels, while Smith calls it a ‘buy and hold for a decade’ candidate, emphasizing long-term fundamentals. In contrast, the majority of models—including those of Benjamin Graham, Philip Fisher, and Howard Marks—flag significant red flags, from valuation concerns to liquidity risks or lack of quality/growth traits. Even the ‘moderate’ camp (like Gerald Loeb or Morgan Housel) leans toward caution, while the efficient-market and trend-following approaches (Malkiel/Bogle, Livermore, Schwager) see little clear edge, suggesting the stock’s appeal is either speculative or overrated. The divide underscores whether one prioritizes cyclical timing, long-term growth, or defensive/enterprising valuation principles.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 93
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 66
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 61
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 59
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 47
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 47
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 44
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 40
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 38
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 36
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 30
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 30
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 29
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 15
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 13
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 2
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 9 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
52.8%
Operating Margin
—
Net Margin
12.7%
EBITDA Margin
—
ROE
11.3%
ROA
5.5%
ROIC
—
EPS
$4.06
Cash
$1.54B
Total Debt
$8.92B
Current Ratio
0.88
Debt/Equity
0.44
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 14.8.2026 | $0.555 |
| 15.5.2026 | $0.555 |
| 14.5.2026 | $0.555 |
| 13.2.2026 | $0.555 |
| 12.2.2026 | $0.555 |
| 14.11.2025 | $0.555 |
| 13.11.2025 | $0.555 |
| 15.8.2025 | $0.528 |
| 14.8.2025 | $0.528 |
| 16.5.2025 | $0.528 |
| 15.5.2025 | $0.528 |
| 14.2.2025 | $0.528 |
How is Fair Value calculated? →
Current Price
$145.83
Estimated Fair Value (DCF)
$73.63
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-49.5%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
9.4%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 9.4% | $2.92B | $2.68B |
| 2 | 7.7% | $3.14B | $2.64B |
| 3 | 5.9% | $3.33B | $2.57B |
| 4 | 4.2% | $3.47B | $2.46B |
| 5 | 2.5% | $3.56B | $2.31B |
Base FCF (last actual year)
$2.67B
Terminal Value
$56.07B
Present Value of Terminal Value
$36.44B
Enterprise Value
$49.10B
Net Debt
$7.38B
Equity Value
$41.72B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$35.79
Tangible Book Value per Share (Tangible NAV)
-$13.00
Sentiment based on basic keywords (not AI) — 11 positive, 6 neutral, 3 negative out of the last 20 articles.
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Zacks · 15.9.2026
Benzinga · 15.9.2026
Trefis · 14.9.2026
Yahoo · 14.9.2026
SeekingAlpha · 14.9.2026
Zacks · 14.9.2026
Yahoo · 14.9.2026
Benzinga · 14.9.2026
Zacks · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 12.9.2026
24/7 Wall St. · 12.9.2026
Yahoo · 11.9.2026
Trefis · 11.9.2026
Yahoo · 11.9.2026
Trefis · 11.9.2026
Yahoo · 10.9.2026
Emerson Electric (EMR) currently has a StockIQ AI score of 49/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
EMR currently scores 49/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, EMR's estimated fair value is $73.63, which is 49.5% below the current price of $145.83. This is one valuation model among several signals in the fair-value category, not a price target.
EMR's technical score is 23/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Debt/equity: 0.44; Price is above the 200-day average; Gross margin: 52.8% — strong.
Based on the real signals StockIQ computed: Estimated fair value: $73.63 vs. price $145.83 (-49.5%); Current ratio: 0.88; Calmar: 0.45 (3y annualized return 13.6% / max drawdown 29.9%).
Yes — EMR has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 12 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Karsanbhai Surendralal Lanca | Open Market Sale | 11.8.2026 | 9,650 | -9,650 | $161.91 |
| Karsanbhai Surendralal Lanca | Open Market Sale | 11.8.2026 | 271,743 | -9,650 | $161.91 |
| Train Michael H. | Open Market Sale | 6.8.2026 | 7,329 | -7,329 | $158.99 |
| Train Michael H. | Open Market Sale | 6.8.2026 | 238,516 | -7,329 | $158.99 |
| Newstead Jennifer | Grant/Award from Employer | 3.8.2026 | 622 | +622 | — |
| Piazza Nicholas J. | Tax Withholding in Shares | 3.8.2026 | 1,453 | -1,453 | $152.51 |
| Newstead Jennifer | Grant/Award from Employer | 3.8.2026 | 622 | +622 | — |
| Piazza Nicholas J. | Tax Withholding in Shares | 3.8.2026 | 30,316 | -1,453 | $152.51 |
| Krishnan Ram R. | Open Market Sale | 1.6.2026 | 11,500 | -11,500 | $141.22 |
| Krishnan Ram R. | Open Market Sale | 1.6.2026 | 159,639 | -11,500 | $141.22 |
| Train Michael H. | Tax Withholding in Shares | 6.4.2026 | 5,286 | -5,286 | $131.61 |
| Train Michael H. | Tax Withholding in Shares | 6.4.2026 | 245,711 | -5,286 | $131.61 |
| Karsanbhai Surendralal Lanca | Open Market Sale | 10.3.2026 | 5,700 | -5,700 | $142.32 |
| Karsanbhai Surendralal Lanca | Open Market Sale | 10.3.2026 | 281,393 | -5,700 | $142.32 |
| Krishnan Ram R. | Gift | 9.3.2026 | 6,680 | +6,680 | — |
| Krishnan Ram R. | Gift | 9.3.2026 | 6,680 | -6,680 | — |
| Krishnan Ram R. | Gift | 9.3.2026 | 53,366 | -6,680 | — |
| Krishnan Ram R. | Gift | 9.3.2026 | 171,139 | +6,680 | — |
| LEVATICH MATTHEW S | Open Market Sale | 10.2.2026 | 1,476 | -1,476 | $162.16 |
| LEVATICH MATTHEW S | Open Market Sale | 10.2.2026 | 24,349 | -1,476 | $162.16 |
| Krishnan Ram R. | Tax Withholding in Shares | 9.2.2026 | 5,319 | -5,319 | $159.06 |
| Piazza Nicholas J. | Open Market Sale | 9.2.2026 | 6,703 | -6,703 | $159.07 |
| Krishnan Ram R. | Tax Withholding in Shares | 9.2.2026 | 60,046 | -5,319 | $159.06 |
| Piazza Nicholas J. | Open Market Sale | 9.2.2026 | 31,664 | -6,703 | $159.07 |
| Karsanbhai Surendralal Lanca | Gift | 5.2.2026 | 5,578 | -5,578 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
8,798,847 shares short as of 2026-08-31 · vs. 12,430,617 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
49.5% of trading volume this week was short selling, vs. 57.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology